Personalized Medicine Market Trends, Share, Industry Size,

Personalized Medicine Market Personalized medicine (PM) market size was estimated at USD 1.57 trillion in 2018 and is anticipated to expand at a CAGR of 10% during the forecast period. Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, […]

Personalized Medicine Market

Personalized medicine (PM) market size was estimated at USD 1.57 trillion in 2018 and is anticipated to expand at a CAGR of 10% during the forecast period.

Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Growing healthcare expenditure levels triggering the need for an effective diagnostic procedure for cancer, growing prevalence of cancer and increasing usage of combination biomarkers for diagnostics are few factors expected to boost market growth.

Get Sample Copy of Personalized Medicine Market at: https://www.orionmarketreports.com/personalized-medicine-market/28258/#ert_pane1-1

The following players are covered in this report:

• 3G Biotech
• Quest Diagnostics
• Laboratory Corporation of America
• Abbott
• Agendia NV
• Asuragen Inc
• Becton Dickinson
• CardioDx Inc.
• Foundation Medicine
• Qiagen
• Siemens Healthcare
• Amgen
• Bristol-Myers Squibb
• GE Healthcare
• Pfizer
• Sanofi
• 23andMe
• Illumina

Personalized Medicines Breakdown Data by Type

• PM Diagnostics
• PM Therapeutics
• Personalized Medical Care
• Personalized Nutrition & Wellness

Personalized Medicines Breakdown Data by Application

• Hospitals Pharmacies
• Retail Pharmacies
• Dietary Care Centers
• Others

A full report of Global Personalized Medicine Market is available at: https://www.orionmarketreports.com/personalized-medicine-market/28258/

Scope of the Report

The research study analyzes the global Personalized Medicine industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Personalized Medicine Market Report

1. What was the Personalized Medicine Market size in 2018 and 2019; what are the estimated growth trends and market forecast (2019-2025).
2. What will be the CAGR of Personalized Medicine Market during the forecast period (2019-2025)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2018? How these segments are expected to grow during the forecast period (2019-2025).
4. Which manufacturer/vendor/players in the Personalized Medicine Market was the market leader in 2018?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

For more customized data, request for report customization @ https://www.orionmarketreports.com/personalized-medicine-market/28258/#ert_pane1-2

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404

About Us:

Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Source Article

Next Post

To Your Good Health: It's best to remain on a statin post-stroke | Columnists

Sat Aug 22 , 2020
Multiple trials have proven that in people who have had an ischemic stroke, statin drugs reduce the risk of a second stroke. This is true even for people with cholesterol results in the normal range. Based on the trial results, high-dose statin drugs (40 mg atorvastatin) are preferred in people […]